This company has been marked as potentially delisted and may not be actively trading. Inovalon (INOV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOwnershipSustainabilityTrendsBuy This Stock INOV vs. QXO, YY, ADEX, LIFW, NHIQ, NH, WEJOF, CHKP, CYBR, and GRABShould you be buying Inovalon stock or one of its competitors? The main competitors of Inovalon include QXO (QXO), JOYY (YY), Adit EdTech Acquisition (ADEX), MSP Recovery (LIFW), NantHealth (NHIQ), NantHealth (NH), Wejo Group (WEJOF), Check Point Software Technologies (CHKP), CyberArk Software (CYBR), and Grab (GRAB). Inovalon vs. Its Competitors QXO JOYY Adit EdTech Acquisition MSP Recovery NantHealth NantHealth Wejo Group Check Point Software Technologies CyberArk Software Grab QXO (NASDAQ:QXO) and Inovalon (NASDAQ:INOV) are both data processing & preparation industry companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Which has stronger earnings & valuation, QXO or INOV? Inovalon has higher revenue and earnings than QXO. QXO is trading at a lower price-to-earnings ratio than Inovalon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQXO$55.95M212.80-$1.07M-$10.05-2.04Inovalon$667.52M7.65$22.58M$0.3496.70 Which has more volatility & risk, QXO or INOV? QXO has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. Comparatively, Inovalon has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Do analysts prefer QXO or INOV? QXO presently has a consensus target price of $32.25, suggesting a potential upside of 57.24%. Given QXO's stronger consensus rating and higher probable upside, research analysts plainly believe QXO is more favorable than Inovalon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QXO 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Inovalon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in QXO or INOV? 58.7% of QXO shares are owned by institutional investors. Comparatively, 33.2% of Inovalon shares are owned by institutional investors. 51.3% of QXO shares are owned by company insiders. Comparatively, 49.8% of Inovalon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is QXO or INOV more profitable? QXO has a net margin of 30.08% compared to Inovalon's net margin of 6.73%. Inovalon's return on equity of 10.97% beat QXO's return on equity.Company Net Margins Return on Equity Return on Assets QXO30.08% 1.58% 1.30% Inovalon 6.73%10.97%4.10% Does the media favor QXO or INOV? In the previous week, QXO had 10 more articles in the media than Inovalon. MarketBeat recorded 10 mentions for QXO and 0 mentions for Inovalon. QXO's average media sentiment score of 0.76 beat Inovalon's score of 0.00 indicating that QXO is being referred to more favorably in the media. Company Overall Sentiment QXO Positive Inovalon Neutral SummaryQXO beats Inovalon on 11 of the 17 factors compared between the two stocks. Get Inovalon News Delivered to You Automatically Sign up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INOV vs. The Competition Export to ExcelMetricInovalonData Processing & Preparation IndustryComputer SectorNASDAQ ExchangeMarket Cap$5.10B$1.34B$29.90B$9.81BDividend YieldN/A3.15%3.09%4.11%P/E Ratio96.705.3751.6025.11Price / Sales7.6523.961,321.19115.16Price / Cash33.3541.5136.2759.05Price / Book6.661.159.486.18Net Income$22.58M-$17.48M$803.97M$265.11M Inovalon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOVInovalonN/A$32.88+0.2%N/A+13.6%$5.10B$667.52M96.701,836QXOQXO3.8866 of 5 stars$19.270.0%$32.71+69.7%+80.7%$11.19B$55.95M-2.11195News CoverageAnalyst ForecastAnalyst RevisionYYJOYY1.5278 of 5 stars$50.65-0.7%$35.00-30.9%+45.1%$2.73B$2.24B15.307,450News CoveragePositive NewsADEXAdit EdTech AcquisitionN/A$5.38flatN/AN/A$47.88MN/A0.007LIFWMSP RecoveryN/A$0.75+0.8%N/A-91.3%$4.90M$10.73M-0.013Gap UpNHIQNantHealthN/A$0.01flatN/A-60.0%$391K$67M0.00340NHNantHealthN/A$0.01flatN/A-60.0%$92K$67.68M0.00340WEJOFWejo GroupN/A$0.00flatN/AN/A$11K$8.40M0.00300High Trading VolumeCHKPCheck Point Software Technologies4.8398 of 5 stars$180.73-1.4%$228.08+26.2%+1.7%$20.16B$2.57B23.536,669Positive NewsShort Interest ↓CYBRCyberArk Software2.1442 of 5 stars$401.86+0.5%$435.11+8.3%+53.3%$19.76B$1.00B-119.251,205Positive NewsGRABGrab2.1593 of 5 stars$4.82-1.2%$5.82+20.7%+64.4%$19.65B$2.80B120.5311,267Trending NewsUpcoming Earnings Related Companies and Tools Related Companies QXO Alternatives JOYY Alternatives Adit EdTech Acquisition Alternatives MSP Recovery Alternatives NantHealth Alternatives NantHealth Alternatives Wejo Group Alternatives Check Point Software Technologies Alternatives CyberArk Software Alternatives Grab Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INOV) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovalon Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovalon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access